Report of the Neuroatypical Conditions Expert Consultative Panel
![Report of the Neuroatypical Conditions Expert Consultative Panel 1 OBI DSMSE stopwatch](https://new.lumindidsc.org/wp-content/uploads/2022/03/OBI-DSMSE-stopwatch.png)
[nectar_scrolling_text scroll_direction=”ltr” scroll_speed=”slowest” text_color=”#0a0a0a” style=”text_outline” outline_thickness=”ultra-thin” text_repeat_number=”5″ text_repeat_divider=”none” overflow=”visible” background_image_animation=”None” custom_font_size=”11vw” custom_font_size_mobile=”15vw”] innovation [/nectar_scrolling_text]Detection of any cognitive impairment as part of the Affordable Care Act’s annual wellness visit in primary […]
Report of the Neuroatypical Conditions Expert Consultative Panel
![Report of the Neuroatypical Conditions Expert Consultative Panel 2 bg](https://new.lumindidsc.org/wp-content/uploads/2022/02/bg-1024x619.png)
Detection of any cognitive impairment as part of the Affordable Care Act’s annual wellness visit in primary or other health care settings for adults with pre-existing neuroatypical or neurodivergent conditions […]
Results From T21RS’s COVID-19 International Survey on Vaccination of Individuals With DS
![Results From T21RS's COVID-19 International Survey on Vaccination of Individuals With DS 3 bg](https://new.lumindidsc.org/wp-content/uploads/2022/02/bg-1024x619.png)
In a study led by the LuMind IDSC Foundation, the T21RS COVID-19 Initiative launched an international survey to obtain information on the safety and efficacy of COVID-19 vaccines for individuals […]
Five Recent Down Syndrome Research Data Articles to Stay Up to Date
![Five Recent Down Syndrome Research Data Articles to Stay Up to Date 4 bg](https://new.lumindidsc.org/wp-content/uploads/2022/02/bg-1024x619.png)
Recently, two institutions in the Down Syndrome Clinical Trials Network (DS-CTN) published five studies about Down syndrome-related health and wellness, ranging from infectious diseases to mental health, skills, and independence. This new […]
LuMind IDSC Statement on CMS Proposed Coverage for Anti-Amyloid AD Drugs
![LuMind IDSC Statement on CMS Proposed Coverage for Anti-Amyloid AD Drugs 5 bg](https://new.lumindidsc.org/wp-content/uploads/2022/02/bg-1024x619.png)
During the past year, LuMind IDSC remained cautiously optimistic about treatment possibilities that the development of new drugs for Alzheimer’s disease may bring to the Down syndrome community. Because people […]
LuMind IDSC and Dr. Nicole White Publish “Parental Perspectives on Research for Down Syndrome”
![LuMind IDSC and Dr. Nicole White Publish “Parental Perspectives on Research for Down Syndrome” 6 bg](https://new.lumindidsc.org/wp-content/uploads/2022/02/bg-1024x619.png)
Dr. Nicole White, Hampus Hillerstrom, LuMind IDSC and a team of experts, recently published an article in the Journal of Applied Research in Intellectual Disabilities, that delves into the intricacies of […]
LuMind IDSC and Team of Experts Publish Article on Aging With DS and the Future of Research
![LuMind IDSC and Team of Experts Publish Article on Aging With DS and the Future of Research 7 bg](https://new.lumindidsc.org/wp-content/uploads/2022/02/bg-1024x619.png)
Dr. James Hendrix, LuMind IDSC’s Chief Scientific Officer, along with a team of Down syndrome experts recently published an article in the Journal of Clinical Medicine, as part of the special issue […]
Expert Chat: A Conversation with Nicole White
![Expert Chat: A Conversation with Nicole White 8 bg](https://new.lumindidsc.org/wp-content/uploads/2022/02/bg-1024x619.png)
From mom of four to Down syndrome researcher. Community Spotlight sat with Nicole White and discussed some of the challenges that prevent parents and caregivers from getting involved in the […]